BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25542052)

  • 1. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
    Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
    Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
    Paño Pardo JR; Serrano Villar S; Ramos Ramos JC; Pintado V
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
    Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
    Martínez-Martínez L; González-López JJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
    Asensio Á; Cantero M; Shaw E; Vergara-López S
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
    Goodman KE; Simner PJ; Tamma PD; Milstone AM
    Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
    Bou G; Vila J; Seral C; Castillo FJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms.
    López-Cerero L; Almirante B
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():10-6. PubMed ID: 25542047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
    Cantón R; Canut A; Morosini MI; Oliver A
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():33-40. PubMed ID: 25542050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC β-lactamases and/or carbapenemases in Spain.
    Machuca J; Agüero J; Miró E; Conejo MDC; Oteo J; Bou G; González-López JJ; Oliver A; Navarro F; Pascual Á; Martínez-Martínez L
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):487-492. PubMed ID: 27345951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenemase-producing Enterobacteriaceae.
    Doi Y; Paterson DL
    Semin Respir Crit Care Med; 2015 Feb; 36(1):74-84. PubMed ID: 25643272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic options for carbapenemase-producing Enterobacteriaceae].
    Salgado P; Gilsanz F; Maseda E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():12-5. PubMed ID: 26365727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
    Cercenado E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
    Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
    Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
    Albiger B; Glasner C; Struelens MJ; Grundmann H; Monnet DL;
    Euro Surveill; 2015; 20(45):. PubMed ID: 26675038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
    Savard P; Carroll KC; Wilson LE; Perl TM
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
    [No Abstract]   [Full Text] [Related]  

  • 20. [KPC carbapenemases: what is at stake in clinical microbiology?].
    Cuzon G; Naas T; Nordmann P
    Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.